Template:Cefuroxime: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Cefuroxime | ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Cefuroxime]]|{{fontcolor|#6C7B8B|Cefuroxime}}]]''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |ZINACEF<sup>®</sup>,CEFUROXIME<sup>®</sup> FDA Package Insert | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime description|Description]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime clinical pharmacology|Clinical Pharmacology]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime microbiology|Microbiology]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime indications and usage|Indications and Usage]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime contraindications|Contraindications]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime warnings and precautions|Warnings and Precautions]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime adverse reactions|Adverse Reactions]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime overdosage|Overdosage]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime dosage and administration|Dosage and Administration]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime how supplied|How Supplied]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime compatibility and stability |Compatibility and Stability ]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime compatibility and stability |Compatibility and Stability ]] | ||
Revision as of 03:04, 6 January 2014
| Cefuroxime|Cefuroxime]] |
|---|
| ZINACEF®,CEFUROXIME® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Compatibility and Stability |
| Direction For Use |
| Labels and Packages |